BofA Securities Downgrades Bristol-Myers Squibb Co. (BMY) to Neutral, 'Await more clarity on commercial execution/success'
Tweet Send to a Friend
(Updated - January 3, 2024 7:39 AM EST)
BofA Securities analyst Geoff Meacham downgraded Bristol-Myers Squibb Co. (NYSE: BMY) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
BofA Securities analyst Geoff Meacham downgraded Bristol-Myers Squibb Co. (NYSE: BMY) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
